Genmab A/s logo

GMAB

Genmab A/s

$21.84

Earnings Summary

Revenue
$5540Mn
Net Profits
$1266Mn
Net Profit Margins
22.85%

Highlights

Revenue:

Genmab A/s’s revenue jumped 16.78% since last year same period to $5540Mn in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated 2.55% jump in its revenue since last 3-months.

Net Profits:

Genmab A/s’s net profit fell -40.54% since last year same period to $1266Mn in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated -10.09% fall in its net profits since last 3-months.

Net Profit Margins:

Genmab A/s’s net profit margin fell -49.08% since last year same period to 22.85% in the Q3 2024. On a quarterly growth basis, Genmab A/s has generated -12.32% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Genmab A/s post its latest quarter earnings

EPS Estimate Current Quarter
0.35
EPS Estimate Current Year
0.35

Highlights

EPS Estimate Current Quarter:

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.35 - a 6.06% jump from last quarter’s estimates.

EPS Estimate Current Year:

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.35.

Key Ratios

Key ratios of the Genmab A/s post its Q3 2024 earnings

Earning Per Share (EPS)
0.29

Highlights

Earning Per Share (EPS):

Genmab A/s’s earning per share (EPS) fell -38.3% since last year same period to 0.29 in the Q3 2024. This indicates that the Genmab A/s has generated -38.3% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-11-06
0.35
0.29
-17.14%
2024-05-02
0.14
0.29
107.14%
2024-08-08
0.33
0.31
-6.06%